Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Camp Hill › NPI 1881690212
Agency

Penn State Health Holy Spirit Medical Center

Penn State Health Holy Spirit Medical Center was paid $10.18M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.

33Billing provider infoPENN STATE HEALTH HOLY SPIRIT MEDICAL CENTER
CAMP HILL, PA 17011
33aNPI1881690212assigned 06/21/2005
33bProvider typeCase Management Agency
28Total paid$10.18M
24GClaims275,375
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Case Management Agency providers in Pennsylvania

Rank by total paid#48 of 206
Median peer was paid$2.13M
This provider vs. median4.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018106$4K
2019498$14K
202038,636$925K
2021134,008$3.54M
202236,262$1.96M
202338,959$2.23M
2024incomplete26,906$1.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 25% 12,349 11,879 $2.51M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 6,887 6,557 $1.64M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 11,385 10,993 $1.56M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.8% 4,549 4,377 $387K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.3% 1,620 1,588 $238K
80053 Comprehensive metabolic panel 2.3% 25,449 24,083 $237K
G0378 Hospital observation service, per hour 2.3% 416 364 $234K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 2,747 2,517 $225K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 1,206 1,153 $202K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 1,696 1,639 $135K
80061 Lipid panel 1.2% 8,251 8,126 $119K
0202U Oncology (prostate), multianalyte, gene expression profiling 1.1% 1,166 1,124 $114K
252 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.0% 21,057 $106K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,114 $100K
84443 Thyroid stimulating hormone (TSH) <1% 5,039 $98K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,385 $70K
70450 Computed tomography, head or brain; without contrast material <1% 1,172 $68K
71045 Radiologic examination, chest; single view <1% 4,122 $67K
71275 Computed tomographic angiography, chest, with contrast material <1% 340 $66K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 127 $65K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,893 $63K
87481 <1% 1,267 $61K
84702 <1% 4,465 $59K
77067 Screening mammography, bilateral, including computer-aided detection <1% 681 $57K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 568 $47K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 1,313 $46K
36415 Collection of venous blood by venipuncture <1% 13,990 $42K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 186 $42K
83036 Hemoglobin; glycosylated (A1C) <1% 5,690 $42K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 479 $40K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 626 $36K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 996 $36K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,456 $36K
76830 Ultrasound, transvaginal <1% 691 $34K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 385 $32K
71046 Radiologic examination, chest; 2 views <1% 1,235 $32K
82607 <1% 2,363 $31K
85027 <1% 4,680 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,308 $30K
84484 <1% 2,994 $29K
96361 Intravenous infusion, hydration; each additional hour <1% 1,652 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 3,393 $27K
72125 Computed tomography, cervical spine; without contrast material <1% 450 $25K
83880 <1% 871 $25K
96375 Therapeutic injection; each additional sequential IV push <1% 1,281 $25K
80050 General health panel <1% 452 $24K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,809 $24K
93971 <1% 344 $23K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 801 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 517 $21K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 505 $21K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 516 $19K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,387 $19K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 355 $18K
86803 <1% 916 $18K
87150 <1% 368 $17K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 330 $17K
71250 <1% 294 $17K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 358 $16K
83605 <1% 2,252 $16K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 526 $15K
88142 <1% 868 $15K
83690 <1% 3,204 $15K
76536 <1% 278 $14K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 226 $14K
86900 <1% 1,360 $14K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 791 $13K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 95 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 243 $13K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,176 $13K
77066 Tomosynthesis, mammo <1% 138 $13K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 280 $13K
81001 <1% 4,477 $11K
76801 <1% 274 $11K
84439 <1% 1,339 $11K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 61 $10K
87631 <1% 69 $10K
70551 Magnetic resonance imaging, brain; without contrast material <1% 56 $10K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 234 $10K
86850 <1% 1,275 $10K
76642 <1% 241 $10K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 55 $9K
82570 <1% 1,351 $9K
83735 <1% 1,675 $9K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 62 $9K
82728 <1% 732 $8K
93970 <1% 92 $8K
82805 <1% 263 $8K
76770 <1% 192 $8K
82043 <1% 995 $8K
76819 Fetal biophysical profile; without non-stress testing <1% 138 $7K
93976 <1% 94 $7K
87340 <1% 549 $7K
84145 <1% 384 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 322 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 206 $7K
87511 <1% 717 $6K
84144 <1% 335 $6K
86618 <1% 251 $6K
85610 <1% 2,169 $6K
87040 <1% 335 $6K
82077 <1% 845 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 259 $6K
93017 <1% 227 $6K
90715 <1% 335 $6K
95811 <1% 13 $6K
70486 <1% 78 $5K
73610 <1% 285 $5K
85379 <1% 529 $5K
A9585 Injection, gadobutrol, 0.1 ml <1% 446 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 117 $5K
83540 <1% 582 $5K
86901 <1% 1,252 $5K
73030 <1% 324 $4K
80081 <1% 48 $4K
83655 <1% 378 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,960 $4K
84146 <1% 169 $4K
84481 <1% 167 $4K
59899 <1% 95 $4K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $4K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 118 $4K
84403 <1% 153 $4K
87109 <1% 246 $4K
94729 <1% 168 $4K
83001 <1% 216 $4K
86762 <1% 245 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 169 $4K
82652 <1% 76 $4K
87186 <1% 465 $4K
87430 <1% 552 $4K
73560 <1% 256 $4K
73630 <1% 311 $4K
94664 <1% 380 $3K
83970 <1% 89 $3K
72100 <1% 173 $3K
82670 <1% 153 $3K
94726 <1% 149 $3K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 31 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 161 $3K
82950 <1% 428 $3K
83002 <1% 175 $3K
86140 <1% 1,017 $3K
86317 <1% 136 $3K
87070 <1% 452 $3K
73130 <1% 258 $3K
86038 <1% 184 $3K
80143 <1% 351 $3K
82550 <1% 428 $3K
70498 <1% 17 $3K
87077 <1% 342 $3K
80179 <1% 343 $3K
85652 <1% 903 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 28 $2K
97161 <1% 97 $2K
85730 <1% 526 $2K
88342 <1% 91 $2K
80076 <1% 250 $2K
97597 <1% 42 $2K
74018 <1% 181 $2K
81003 <1% 880 $2K
73502 <1% 132 $2K
94060 <1% 186 $2K
82962 <1% 1,494 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 61 $2K
83550 <1% 469 $2K
83525 <1% 166 $2K
70496 <1% 15 $2K
77065 Tomosynthesis, mammo <1% 28 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,265 $2K
86592 <1% 578 $2K
93975 <1% 15 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 168 $2K
97162 <1% 140 $2K
82746 <1% 200 $2K
72110 <1% 80 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,242 $2K
84100 <1% 444 $2K
81025 <1% 502 $2K
84156 <1% 364 $1K
84153 <1% 58 $1K
93880 <1% 31 $1K
84550 <1% 222 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 468 $1K
82375 <1% 282 $1K
82947 <1% 298 $1K
84270 <1% 41 $1K
86431 <1% 146 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,302 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,625 $1K
73564 <1% 49 $964.76
J2785 Injection, regadenoson, 0.1 mg <1% 17 $958.88
87088 <1% 123 $953.28
85018 <1% 331 $914.08
72170 <1% 136 $899.30
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 854 $895.02
Q3014 Telehealth originating site facility fee <1% 147 $894.63
76857 <1% 45 $846.05
J0780 Injection, prochlorperazine, up to 10 mg <1% 335 $843.68
73590 <1% 58 $840.27
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,696 $761.40
96376 <1% 170 $750.84
73110 <1% 68 $705.87
82565 <1% 117 $657.96
83050 <1% 263 $614.45
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,993 $537.35
80320 <1% 56 $518.60
73090 <1% 46 $505.41
87522 Neg quan hep c or qual rna <1% 12 $483.26
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 72 $462.73
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,097 $453.84
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 16 $435.21
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 118 $376.50
88304 <1% 45 $341.20
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 26 $332.00
86800 <1% 16 $331.90
86696 <1% 13 $322.50
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 88 $322.13
80329 <1% 28 $317.73
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 50 $306.00
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 35 $292.16
87075 <1% 44 $282.83
86695 <1% 13 $274.54
86694 <1% 12 $271.46
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 53 $269.06
82040 <1% 68 $228.55
3044F <1% 588 $206.41
80164 <1% 14 $206.37
73562 <1% 15 $199.30
84520 <1% 41 $191.98
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 806 $191.83
S0028 Injection, famotidine, 20 mg <1% 113 $186.51
74230 <1% 12 $186.30
J1815 Injection, insulin, per 5 units <1% 181 $176.82
87205 <1% 49 $157.46
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 229 $154.92
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,174 $144.00
73070 <1% 14 $143.92
86376 <1% 16 $142.31
J2060 Injection, lorazepam, 2 mg <1% 305 $132.53
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 206 $122.89
C1769 Guide wire <1% 12 $108.00
J7050 Infusion, normal saline solution, 250 cc <1% 385 $101.50
85007 <1% 26 $100.67
J1644 Injection, heparin sodium, per 1000 units <1% 402 $98.29
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 127 $90.62
94618 <1% 16 $72.49
C1729 Catheter, drainage <1% 14 $72.00
J1650 Injection, enoxaparin sodium, 10 mg <1% 155 $68.06
J7120 Ringers lactate infusion, up to 1000 cc <1% 896 $52.68
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 224 $51.10
J8540 Dexamethasone, oral, 0.25 mg <1% 41 $49.25
J1630 Injection, haloperidol, up to 5 mg <1% 13 $15.37
90834 Psychotherapy session, about 45 minutes <1% 117 $13.48
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 42 $4.13
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 209 $0.00
90837 Psychotherapy session, about an hour 0% 35 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 57 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 135 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 47 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 16 $0.00
J3490 Unclassified drugs 0% 251 $0.00
J2704 Injection, propofol, 10 mg 0% 1,334 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSNYDER, KYLE (PRESIDENT, INTERIM)
Same official

Other billing entities under SNYDER, KYLE

Full network →
ProviderLocationPaid
Penn State Health Hampden Medical CenterEnola, PA$5.07M
Penn State Health Holy Spirit Medical CenterCamp Hill, PA$2.94M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.